Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Selective Digestive Decontamination in the ICU With Rates of Antibiotic-resistant Bacteria

NCT04839653 is registered in ClinicalTrials.gov with MEDSI Clinical Hospital 1, ICU as lead sponsor.

NCT NCT04839653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04839653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Selective Digestive Decontamination in the ICU With Rates of Antibiotic-resistant Bacteria
Lead sponsor
MEDSI Clinical Hospital 1, ICU
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2021
Completion date
April 30, 2023
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bloodstream infection, critical illness, pneumonia, pneumonia, ventilator-associated, respiratory distress syndrome, respiratory tract infections, sepsis